Evaluation of immunogenicity and reactogenicity of recombinant DNA hepatitis B vaccine produced in India

doi:10.3748/wjg.v11.i45.7165

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 45

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2495)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

280

HTML

1978

Figures (1-1)

222

Sum=2480

Dec 7, 2005 (publication date) through Nov 30, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Dec 7, 2005; 11(45): 7165-7168
Published online Dec 7, 2005. doi: 10.3748/wjg.v11.i45.7165

Full Size Figure Download Figure

Figure 1 Efficacy of Enivac-HB in study participants by gender variation (A) and age (B) on the 90^th d evaluation after the initial vaccination. The anti-HBs titer is expressed in milli-international unit per milliliter.

Citation: Hussain Z, Ali SS, Husain SA, Raish M, Sharma DR, Kar P. Evaluation of immunogenicity and reactogenicity of recombinant DNA hepatitis B vaccine produced in India. World J Gastroenterol 2005; 11(45): 7165-7168
URL: https://www.wjgnet.com/1007-9327/full/v11/i45/7165.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i45.7165